Background.Keratosis pilaris (KP) is a common benign follicular disorder for which various topical and laser treatments have been used, with limited efficacy.
a,bMark S. Nestor, MD, PhD; aNicole Swenson, DO; aAngela Macri, DO; aMitchell Manway, DO; aPaige Paparone, DO aCenter for Clinical and Cosmetic Research and Center for Cosmetic Enhancement, Aventura, Florida; bDepartment of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida Disclosure: Dr. Nestor is a
Gao Yang, MD, Laser Center, Jinshan Hospital, Fudan University, Shanghai, China; Leihong Flora Xiang, MD, PhD Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China; Michael H. Gold, MD, Gold Skin Care Center, Tennessee Clinical Research Center, Nashville, Tennesee; Vanderbilt University School of Medicine, Department of Dermatology; Vanderbilt University School
Michael H. Gold, MD, Tennessee Clinical Research Center, Nashville, Tennessee; Anneke Andriessen; RBC Consultants, The Netherlands Julie Biron, Tennessee Clinical Research Center, Nashville, Tennessee; Disclosure: Dr. Gold is a consultant to, performs research for, speaks for, and receives honoraria from Pharos Life; Ms. Andriessen and Ms. Biron report no relevant
Michael H. Gold, MD; Tennessee Clinical Research Center, Nashville, Tennessee; Anneke Andriessen; RBC Consultants, The Netherlands; Julie Biron; Tennessee Clinical Research Center, Nashville, Tennessee; Hinke Andriessen; RBC Consultants, The Netherlands
J Clin Aesthet Dermatol. 2021;14(11):E64–E75. by Suparuj Lueangarun, MD, MSc; Poom Visutjindaporn, MD; Yardnapar Parcharoen, PhD; Pollawat Jamparuang, BSc; and Therdpong Tempark, MD Drs. Lueangarun and Visutjindaporn are with the Division of Dermatology, Chulabhorn International College of Medicine, Thammasat University, in Pathum Thani, Thailand. Dr. Parcharoen is with the Chulabhorn International
J Clin Aesthet Dermatol. 2021;14(10):19–24. by Barry I. Galitzer, MD Dr. Galitzer is with the Skin Center in Fort Lauderdale, Florida. FUNDING: This study was supported by Biofrontera, Inc. DISCLOSURES: The author reports no conflicts of interest relevant to the content of this article. ABSTRACT: Background. Actinic keratoses (AKs) are sun-induced
J Clin Aesthet Dermatol. 2021;14(10):E53–E65. by Nathalie C. Zeitouni, MDCM, FRCPC; Neal Bhatia, MD; Roger I. Ceilley, MD; Joel L. Cohen, MD; James Q. Del Rosso, DO; Angela Y. Moore, MD; Gilly Munavalli, MD, MHS, FACMS; David M. Pariser, MD, FACP, FAAD; Todd Schlesinger, MD; Daniel M. Siegel, MD, MS;
J Clin Aesthet Dermatol. 2021;14(7):16–21 by Martin Wade, BMed Sci, MBBS, FACD; Vanessa Charest, BSc; Bruno Ballardin, B. Eng, MBA; Deirdre Edge, PhD; and Michael Canova Engelbrecht Nielsen, PhD Dr. Wade, Ms. Charest, and Mr. Ballardin are with the London Skin and Hair Clinic in London, England. Drs. Edge and
Dear Editor: In their article, “Safety and efficacy of aminolevulinic acid 10% topical gel versus aminolevulinic acid 20% topical solution followed by blue-light photodynamic therapy for the treatment of actinic keratosis on the face and scalp: A randomized, double-blind study,” Nestor et al assessed the response of actinic keratosis (AK)
J Clin Aesthet Dermatol. 2019;12(3):32–38 by Mark S. Nestor, MD, PhD; Brian Berman, MD, PhD; Jigesh Patel, BS; and Alec Lawson Drs. Nestor and Berman and Messrs. Patel and Lawson are with the Center for Clinical and Cosmetic Research in Aventura, Florida. Drs. Nestor and Berman are also with the
by Ajay J. Deshpande, MBBS, DVD, DNB Dr. Deshpande is with the Maharashtra Medical Foundation Joshi Hospital in Pune, India. Funding: No funding was provided for this article. Disclosures: The author has no conflicts of interest relevant to the content of this article. Abstract: Background: Acne vulgaris is a self-limiting,
by Glynis Ablon, MD, FAAD Dr. Ablon is with the Ablon Skin Institute and Research Center in Manhattan Beach, California. Funding: No funding was provided for this article. Disclosures: The author has no conflicts of interest to relevant to the content of this article. Abstract: Within the field of dermatology,
Michael H. Gold, MD; Julie A. Biron, BSc Tennessee Clinical Research Center, Nashville, Tennessee
J Clin Aesthet Dermatol. 2024;17(11):39–44. by Mai Abdelraouf Osman, MD, PhD; Nevien Ahmed Samy, MD, PhD; and Ahmed Shami Jasim, MSc Drs. Osman and Samy are with the National Institute of Laser Enhanced Sciences (NIlES) in Giza Governorate, Egypt. Dr. Jasim is with the Burn Center at Fallujah Teaching Hospital
J Clin Aesthet Dermatol. 2024;17(10):E69–E75. by Moetaz El-Domyati, MD; Wael Hosam El-Din, MD; Walid Medhat, MD; Yasmin Khaled, MSc; and Michel R. Ibrahim, MD All authors are affiliated with the Department of Dermatology, STDs and Andrology, Faculty of Medicine at Minia University in Al-Minya, Egypt. FUNDING: No funding was provided
By Erin Hennessey, DNP, APRN, FNP-C Ms. Hennessey is the Owner of Blush Aesthetics in Perrysburg and Toledo, Ohio, and Assistant Professor, Nursing, Gonzaga University in Spokane, Washington. Funding: No funding was provided for this study. Disclosures: KH is a key opinion leader for Sciton, Inc., and receives honoraria for
J Clin Aesthet Dermatol. 2024;17(8):62–69. by Nooshin Bagherani MD, MA, PhD Candidate; Alireza Ghanadan, MD; Golshan Mirmomeni, MA; Alireza Firooz, MD; Bruce R. Smoller, MD; Reza Shojaei, MD; Haniyeh Rafipour, MD; Negin Bagherani, bS; Mansoreh Abdolhosseini, PhD Candidate; and Gholamreza Tavoosidana, PhD Dr. Bagherani is with the Department of Molecular
J Clin Aesthet Dermatol. 2024;17(1):41–44. by Ally-Khan Somani, MD, PhD; Sherrif F. Ibrahim, PhD, MD; Michael Tassavor, MD; Jane Yoo MD; and Aaron S. Farberg, MD Dr. Somani is with the Department of Dermatology at Indiana’s University School of Medicine in Indianapolis, Indiana. Dr. Ibrahim is with Rochester Dermatologic
J Clin Aesthet Dermatol. 2023;16(12):46–51. by Daniel Piacquadio, MD; Brian Berman, MD, PhD; Daniel M. Siegel, MD; Neal Bhatia, MD; Jason Brocato, PhD; Nicholas Squittieri, MD; and David M. Pariser, MD Drs. Piacquadio and Bhatia are with Therapeutics, Inc., in San Diego, California. Dr. Berman is with Center for Clinical
